IRIS
COSTANZO, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.632
AS - Asia 8.388
EU - Europa 2.192
SA - Sud America 1.642
AF - Africa 353
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 19
AN - Antartide 1
Totale 25.255
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.327
SG - Singapore 5.223
CN - Cina 1.399
BR - Brasile 1.365
VN - Vietnam 806
FI - Finlandia 376
IE - Irlanda 330
IT - Italia 278
DE - Germania 243
NG - Nigeria 225
HK - Hong Kong 224
FR - Francia 192
GB - Regno Unito 187
CA - Canada 171
IN - India 165
NL - Olanda 126
AR - Argentina 108
BD - Bangladesh 96
MX - Messico 73
TR - Turchia 71
SE - Svezia 67
RU - Federazione Russa 57
BE - Belgio 53
EC - Ecuador 51
ES - Italia 51
IQ - Iraq 50
ID - Indonesia 44
ZA - Sudafrica 43
UA - Ucraina 42
PK - Pakistan 40
PL - Polonia 38
JP - Giappone 33
IL - Israele 28
CL - Cile 24
VE - Venezuela 22
CO - Colombia 21
AU - Australia 20
JO - Giordania 19
PE - Perù 18
SA - Arabia Saudita 18
UZ - Uzbekistan 18
CZ - Repubblica Ceca 17
PH - Filippine 17
PY - Paraguay 16
RO - Romania 16
GR - Grecia 15
MY - Malesia 15
EG - Egitto 14
TN - Tunisia 14
DO - Repubblica Dominicana 12
JM - Giamaica 12
KR - Corea 12
A2 - ???statistics.table.value.countryCode.A2??? 11
AE - Emirati Arabi Uniti 11
AZ - Azerbaigian 11
CH - Svizzera 11
LT - Lituania 11
MA - Marocco 11
NP - Nepal 11
DZ - Algeria 10
HU - Ungheria 10
OM - Oman 10
KE - Kenya 9
AL - Albania 8
AT - Austria 8
ET - Etiopia 8
RS - Serbia 8
TH - Thailandia 8
UY - Uruguay 8
KZ - Kazakistan 7
NZ - Nuova Zelanda 7
DK - Danimarca 6
IR - Iran 6
KG - Kirghizistan 6
PA - Panama 6
PS - Palestinian Territory 6
PT - Portogallo 6
BG - Bulgaria 5
HN - Honduras 5
MD - Moldavia 5
NI - Nicaragua 5
NO - Norvegia 5
SN - Senegal 5
XK - ???statistics.table.value.countryCode.XK??? 5
AO - Angola 4
BO - Bolivia 4
CR - Costa Rica 4
LB - Libano 4
LV - Lettonia 4
LY - Libia 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
BN - Brunei Darussalam 3
EU - Europa 3
KH - Cambogia 3
KW - Kuwait 3
PR - Porto Rico 3
Totale 25.208
Salva come PNG Salva come JPEG
Città #
Singapore 2.215
Chandler 1.695
Wilmington 1.446
Ashburn 1.084
The Dalles 730
Shanghai 672
San Jose 668
San Mateo 575
Dallas 489
Ann Arbor 453
Helsinki 373
Boardman 356
Dublin 329
Ho Chi Minh City 294
New York 283
Beijing 279
Lawrence 261
Princeton 261
Leawood 259
Benin City 223
Hong Kong 206
Hanoi 181
Los Angeles 163
Fairfield 146
Paris 138
Woodbridge 131
Santa Clara 126
São Paulo 125
Amsterdam 99
Milan 79
London 77
Seattle 71
Toronto 68
Buffalo 61
Phoenix 51
Brussels 50
Orem 46
San Diego 43
Council Bluffs 41
Belo Horizonte 40
Rio de Janeiro 37
Chennai 35
Falls Church 33
Brooklyn 32
Haiphong 32
Chicago 31
Da Nang 30
Houston 30
Tokyo 29
Kocaeli 28
Montreal 28
Warsaw 28
Falkenstein 27
Johannesburg 26
Manchester 26
Norwalk 25
San Francisco 25
Charlotte 23
Columbus 19
Frankfurt am Main 19
Munich 19
Atlanta 18
Guarulhos 18
Mexico City 18
Amman 17
Hải Dương 17
Tashkent 17
Campinas 16
Goiânia 16
Quito 16
Redmond 16
Boston 15
Curitiba 15
Moscow 15
Salvador 15
Baghdad 14
Can Tho 14
Dhaka 14
Lima 14
New Delhi 14
Guayaquil 13
Istanbul 13
Lahore 13
Sorocaba 13
Stockholm 13
Assago 12
Buenos Aires 12
Fortaleza 12
Poplar 12
Porto Alegre 12
Biên Hòa 11
Brasília 11
Brno 11
Jakarta 11
Pasadena 11
Pune 11
Rome 11
Mumbai 10
Ninh Bình 10
Baku 9
Totale 15.999
Salva come PNG Salva come JPEG
Nome #
Living with Chronic Spontaneous Urticaria in Italy: A Narrative Medicine Project to Improve the Pathway of Patient Care 332
Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study 284
Melanoma in Adolescents and Young Adults (AYAs): An Italian Multi-Centric Retrospective Experience 202
y Clinical similarity of the biosimilar ABP 501 compared with adalimumab after single transition: long-term results from a randomized controlled, double-blind, 52-week, phase III trial in patients with moderate-to-severe plaque psoriasis 149
CD28 costimulation regulates FOXP3 in a RelA/NF-κB-dependent mechanism. 144
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias 120
DNA Methylation Signature in Monozygotic Twins Discordant for Psoriatic Disease 117
A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naive patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial 117
Adalimumab for severe psoriasis and psoriatic arthritis: An open-label study in 30 patients previously treated with other biologics 116
Chronic Hand Eczema (CHE): A Narrative Review 112
IL-21 in the pathogenesis and treatment of skin diseases. 112
Actinic keratosis treated with an immune response modifier: a case report of six patients 112
Brodalumab: a new way to inhibit IL-17 in psoriasis 112
Rosacea-like Acute Reaction After Hyaluronic Acid Dermal Filler 111
'Living with chronic urticaria': a study through narrative medicine to improve the quality of care 110
A role of p73 in mitotic exit 108
FGF8, c-Abl and p300 participate in a pathway that controls stability and function of the Delta Np63 alpha protein 106
How to make a skin-tight dress: the p63/claudin-1 connection 105
Herpes simplex virus disrupts NF-kappa B regulation by blocking its recruitment on the I kappa B alpha promoter and directing the factor on viral genes 105
A p38-dependent pathway regulates DNp63 DNA binding to p53 dependent promoters in UV-induced apoptosis of keratinocytes 104
Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes. 104
A symphony of regulations centered on p63 to control development of ectoderm-derived structures. 103
Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway 103
Psoriasis: from pathogenesis to novel therapeutic approaches. 102
A feedback regulatory loop between p63 and Dlx3: implications for epidermal differentiation 102
Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis 101
A p38-dependent pathway regulates Delta Np63 DNA binding to p53-dependent promoters in UV-induced apoptosis of keratinocytes 101
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis 101
Age and gender influence on HIDRAdisk outcomes in adalimumab-treated hidradenitis suppurativa patients 100
A role for the p63-IKKalpha pathway in the development of ectodermal dysplasias 99
A fatal case of COVID-19 infection presenting with an erythema multiforme-like eruption and fever 98
Efficacy and safety of JAK inhibitors in patients aged > 60 years with moderate-to-severe atopic dermatitis: a 52-week multicenter, real-life study-IL AD (Italian Landscape Atopic Dermatitis) 98
p63-dependent and independent mechanisms of nectin-1 and -4 regulation in the epidermis. 95
A myogenic differentiation checkpoint activated by genotoxic stress 95
Infliximab in psoriasis and psoriatic arthritis. 95
Adalimumab for severe psoriasis and psoriatic arthritis: an open label study in 30 patients previously treated with other biologics 93
The p53/p63/p73 family of transcription factors: overlapping and distinct functions. . 2000 May;113 ( Pt 10):1661-70 92
Adalimumab for the treatment of severe psoriasis and psoriatic arthritis 92
Zosteriform metastasis of occult bronchogenic carcinoma. 92
p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis 92
Specific Infiltrate of Hodgkin Lymphoma at Site of Cellulitis Mimicking Secondary Cutaneous Involvement 92
p63 induces key target genes required for epidermal morphogenesis 91
Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris. 91
Efalizumab 91
No metagenomic evidence of tumorigenic viruses in cancers from a selected cohort of immunosuppressed subjects 90
A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal study 90
Programmed cell death in the skin 89
Role of the HLA-C(star)06 allele in clinical response to ustekinumab: evidence from real life in a large cohort of European patients 89
Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey 89
CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappa B subunits on IL-8 and Bcl-xL gene promotors 88
Ustekinumab for treatment of plaque psoriasis in a patient with Down syndrome. 88
Diagnosis and management of moderate to severe adult atopic dermatitis: a Consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC), and the Italian Society of Allergological, Environmental and Occupational Dermatology (SIDAPA) 88
Topical use of valproic acid for the prevention or treatment of skin disorders 88
Anti-IL17 and anti-IL23 biologic drugs for scalp psoriasis: A single-center retrospective comparative study 88
Additional complexity in p73: induction by mitogens in lymphoid cells and identification of two new splicing variants epsilon and zeta 87
Autoinflammatory and autoimmune conditions at the crossroad of COVID-19 87
Treatment of psoriasis and psoriatic arthritis. 86
Living Matter Observations with a Novel Hyperspectral Supercontinuum Confocal Microscope for VIS to Near-IR Reflectance Spectroscopy 86
IKKalpha downregulation in psoriasis: New insights in the pathway regulating keratinocyte proliferation 86
Noninferiority of biosimilar MSB110222 to reference adalimumab for chronic plaque psoriasis 86
The tumor suppressor activity of IKK alpha in stratified epithelia is exerted in part via the TGF-beta anti proliferative pathway 86
High-dose intravenous immunoglobulin for severe drug reactions: Efficacy in toxic epidermal necrolysis 86
Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses – IL PSO (Italian landscape psoriasis) 85
Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling 85
HLACw6 predisposes to clinical response to IL12/23 blocker ustekinumab: Results of short- and long-term treatment in anti-TNF naive patients 85
IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis 85
Two new p73 splice variants, gamma and delta, with different transcriptional activity 84
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target. 84
c-E10 is a caspase-recruiting domain-containing protein that interacts with components of death receptors signaling pathway and activates nuclear factor-kappaB 84
Patient-relevant needs and treatment goals in nail psoriasis. 84
Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope 84
TRIM8 and p53: making the right decision. 83
The p73 gene is an anti-tumoral target of the RAR beta/gamma-selective retinoid tazarotene 83
Keratosis punctata palmoplantaris and malignancies: Case report 83
Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab 83
Patients with moderate to severe plaque psoriasis: one year after the European Medicines Agency recommendation of efalizumab suspension. 83
Prevalence and genomic variability of transfusion transmitted virus in Italian cryptogenic chronic liver disease and healthy blood donors. 83
Biologic therapies for plaque type psoriasis in patients with previous malignant cancer: long-term safety in a single- center real-life population 83
Fas/Apo1 mutations and autoimmune lymphoproliferative syndrome in a patient with type 2 autoimmune hepatitis. Gastroenterology. 1997 Oct;113(4):1384-9 83
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: results from extension phase of the SUPREME study 83
Apremilast for the treatment of palmo-plantar non-pustular psoriasis: A real-life single-center retrospective study 83
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy 81
Delta Np63 knockdown mice: a mouse model for AEC syndrome 81
Role of p63 in keratinocyte differentiation and proliferation 81
Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody. 80
Long-term treatment with adalimumab in psoriatic arthritis: serum adalimumab concentration, immunogenicity and the link with clinical response 80
Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients 80
DNp73 alpha protects myogenic cells from apoptosis. 79
HLA‐C*06 and psoriasis: susceptibility, phenotype, course and response to treatment 79
Ashy dermatosis: clinico-pathological associations in two cases] 79
Vav cooperates with CD28 to induce NF-kappa B activation via a pathway involving Rac-1 and mitogen-activated kinase kinase 1 79
Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study 78
Clinical similarity of biosimilar ABP 501 to adalimumab in the treatment of patients with moderate to severe plaque psoriasis: A randomized, double-blind, multicenter, phase III study 78
p73 is regulated by phosphorylation at the G2/M transition 78
Elementi di dermatologia 78
Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas. 78
Cutaneous and Mucosal Manifestations of Sjögren’s Syndrome 78
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 77
Safety and efficacy study on etanercept in patients with plaque psoriasis 77
DLX5, FGF8 and the Pin1 isomerase control ΔNp63α protein stability during limb development: a regulatory loop at the basis of the SHFM and EEC congenital malformations. 77
Totale 9.766
Salva come PNG Salva come JPEG
Categoria #
all - tutte 169.505
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 169.505
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021274 0 0 0 0 0 0 0 0 0 0 0 274
2021/20221.472 49 12 19 323 21 38 57 195 143 111 413 91
2022/20234.235 595 166 374 543 399 390 5 353 790 319 242 59
2023/20242.627 158 237 592 68 54 222 174 416 44 54 211 397
2024/20254.124 107 80 45 64 66 427 260 396 571 981 533 594
2025/202610.397 1.598 688 662 999 392 426 3.116 519 549 591 407 450
Totale 25.530